Zusammenfassung
Die chronisch-obstruktive Lungenerkrankung (COPD) hat große Auswirkungen auf die Lebensqualität der betroffenen Patienten. Bei der krankheitsbezogenen Lebensqualität ist die Multi-Dimensionalität zu beachten, d.h., die Lebensqualität umfasst mehrere Bereiche. Die emotionalen Folgen sind vielfältig, oft kommt es bei schwerer COPD zu Angststörungen, Depressionen [21,22], emotionaler Labilität oder erhöhter Reizbarkeit. Die Krankheit vermindert das Selbstvertrauen, und die Patienten fühlen sich häufig ausgeliefert, hilflos, einsam und mit ihren Beschwerden nicht ernst genommen. Auffallende Krankheitssymptome wie Zyanosen, abweichendes Körpergewicht, Uhrglasnägel, Trommelschlegelfinger und chronischer Husten mit Auswurf sind für die Betroffenen stigmatisierend, verunsichern das Selbstwertgefühl und können zusätzlich die soziale Integration erschweren. Untersuchungen bei COPD-Patienten haben gezeigt, dass die Prävalenz von Angst und Depression zwischen 2–50% variiert [23, 24, 25]. Van Ede et al. stellten in Übereinstimmung eine Prävalenz von 6–24% fest [22].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Seemungal TA, Donaldson GC, Paul EA et al. (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 1418–1422
Spencer S, Calverley PM, Burge PS, Jones PW (2004) Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 23: 698–702
Doll H, Grey-Amante P, Duprat-Lomon I (2002) Quality of life in acute exacerbation of chronic bronchitis: results from a German population study. Respir Med 96: 39–51
Jones PW, Stahl E (2003) Reducing exacerbations leads to a better health-related quality of life in patients with COPD. Eur Respir J, 22: Suppl. 45, 238
Lacasse Y, Wong E, Guyatt GH (1996) Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 348: 1115–1119
Lacasse Y, Guyatt GH, Goldstein RS (1997) The components of a respiratory rehabilitation program: a systematic overview. Chest 111: 1077–1088
Lacasse, Y, Brosseau L, Milne S (2003) Pulmonary rehabilitation for chronic obstructive pulmonary disease. The Cochrane Library Issue 1, Oxford
Criner G, Cordova FC, Leyenson et al. (1999) Randomised controlled trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic pulmonary disease. Am J Respir Crit Care Med 160: 2018–2027
Verrill D, Barton C, Beasley W, Lippard WM (2005) The effects of shortterm and long-term pulmonary rehabilitation on functional capacity, perceived dyspnea, and quality of life. Chest 128: 673–683
Benzo R, Flume PA, Turner D, Tempest M (2000) Effect of pulmonary rehabilitation on quality of life in patients with COPD: the use of SF-36 summary scores as outcomes measures. J Cardiopulm Rehabil 20: 231–234
Ries AL, Make BJ, Lee SM et al. (2005) The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest 128: 3799–3809
Sewell L, Singh S J, Williams JE, Collier R, Morgan MD (2006) How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks. Thorax 61: 767–771
Wijkstra PJ, Vergert EM t, Otten AR v et al. (1994) Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax 49: 465–467
Puhan MA, Behnke M, Laschke M et al. (2004) Self-administration and standardisation of the chronic respiratory questionnaire: a randomised trial in three German-speaking countries. Respir Med 98: 342–350
Puhan MA, Schunemann HJ, Frey M, Scharplatz M, Bachmann LM (2005) How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction. Thorax 60: 367–375
Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW (1987) A measure of quality of life for clinical trials in chronic lung disease. Thorax 42: 773–778
Mahler DA, Mackowiak JI (1995) Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest 107: 1585–1589
Bullinger M (1995) German translation and psychometric testing of the SF-36 health survey: preliminary results from the IQOLA Project. International quality of life assessment. Soc Sci Med 41: 1359–1366
Harper R, Brazier JE, Waterhouse JC et al. (1997) Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax 52: 879–887
Gandek B, Ware JE, Aaronson NK et al. (1998) Tests of data quality, scaling assumptions and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51: 1149–1158
Ede L v, Yzermans CJ, Brouwer HJ (1999) Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 54: 688–692
Mikkelsen RL, Middelboe T, Pisinger C, Stage K (2004) Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 58: 65–70
Light RW, Merrill EJ, Despars JA, Gordon GH, Mutalipassi LR (1985) Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest 87: 35–38
Karajgi B, Rifkin A, Doddi S, Kolli R (1990) The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry 147: 200–201
Dowson C, Laing R, Barraclough R et al. (2001) The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. NZ Med J 114: 447–449
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
van Gestel, A.J.R., Teschler, S., Teschler, H. (2010). Lebensqualität. In: Physiotherapie bei chronischen Atemwegs- und Lungenerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01435-2_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-01435-2_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01434-5
Online ISBN: 978-3-642-01435-2
eBook Packages: Medicine (German Language)